However, the efficacy of current IL-8 antagonistic treatments is limited, and our understanding of how CAFs-derived circRNAs mediate platinum resistance in pancreatic cancer is not yet clear. This evidence concerns the gene CXCL8 and familial pancreatic carcinoma.